Nasal Drug Delivery Devices Market Worldwide Industry Share, Size, Companies Profile, Gross Margin, Trend, Future Demand, Forecast Till 2026

Posted on Apr 9 2021 4:09 AM

"Nasal Drug Delivery Devices Market by Top Key Players are Consort Medical plc, Teva Pharmaceutical Industries Ltd., H&T Presspart Manufacturing Ltd, 3M, GOFIRE INC., Nemera, AptarGroup, Inc., Vectura Group plc "

Nasal Drug Delivery Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027. The global Nasal Drug Delivery Market size is prognosticated to reach USD 81.85 billion by 2026 attributable to the increasing number of the patient population and the rising prevalence of pulmonary disorders worldwide. This information is provided in a recently published report by Fortune Business Insights™ titled, “Nasal Drug Delivery Market Size, Share and Global Trend By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Geography Forecast till 2026.” As per the report’s description, the market size was USD 46.34 billion in 2018 and is likely to exhibit a CAGR of 7.5% between 2019 to 2026.

For more information in the analysis of this report, visit:

Leading Players operating in the Nasal Drug Delivery Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Consort Medical plc. (United Kingdom)
  • Teva Pharmaceutical Industries Ltd.
  • H&T Presspart Manufacturing Ltd.
  • 3M
  • Nemera
  • AptarGroup, Inc. (United States)
  • Vectura Group plc (United Kingdom)
  • Others

Market Drivers:

Rising Awareness About Nasal Spray and its Benefits will Help Market Gain Impetus

The increasing prevalence of respiratory disorders among people is a major factor boosting the Nasal Drug Delivery Market growth. Additionally, the increasing prevalence of asthma and chronic obstructive pulmonary disease (COPD) cases is also aiding to the expansion of the market for pulmonary drug delivery devices. Besides this, analyst at Fortune Business Insights™ says, “The increasing patient population and the rising demand for inhalers are encouraging companies to set up new manufacturing units. This is further expected to drive the overall market in the forecast period.”

Request a Sample Copy of the Research Report:

On the flipside, lack of awareness about inhalers along with their usage, especially amongst the older population may cause hindrance to the overall market. Nevertheless, the rising awareness about the benefits of DPIs and MDIs is expected to help increase their popularity in the market. This, as a result, will give significant impetus to the market in the long run.

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market. Furthermore, the report offers a detailed analysis and information as per Nasal Drug Delivery Market Growth Analysis by manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.

Competitive Landscape –

Demand for Nasal Drug Products to Fuel as Companies Focus on Launching Eco-friendly Inhalers

Manufacturers of the intranasal drug delivery devices are focusing on new product launches to stand out in the market competition and are therefore investing huge sums into research and development for the same. In addition to this, companies are trying to launch environment-friendly inhalers for COPD and asthma patients. They are also promoting advanced technologies by introducing software and advanced services for enhanced user experience. Most of the startup companies in this market are trying to implement applications of agglomerated vesicle technology, particle engineering, nanotechnology, and others for delivering medications to COPD and asthma patients.


By Type

  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Nebulizers

By Application

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America (the U.S. and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
  • Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)

Nasal Drug Delivery Highlights of the Report:

  1. Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
  2. Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
  3. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  4. Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  5. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market

Have Any Query? Ask Our Experts:

Key questions answered in the report:

  1. What will the market growth rate of Nasal Drug Delivery market in 2027?
  2. What are the key factors driving the global Nasal Drug Delivery market?
  3. Who are the key manufacturers in Nasal Drug Delivery market space?
  4. What are the market opportunities, market risk and market overview of the Nasal Drug Delivery market?
  5. What are sales, revenue, and price analysis of top manufacturers of Nasal Drug Delivery market?
  6. Who are the distributors, traders and dealers of Nasal Drug Delivery market?
  7. What are the Nasal Drug Delivery market opportunities and threats faced by the vendors in the global Nasal Drug Delivery industry?
  8. What are sales, revenue, and price analysis by types and applications of Nasal Drug Delivery market?
  9. What are sales, revenue, and price analysis by regions of Nasal Drug Delivery industry?

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.


US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin | Twitter | BLogs